Three Biopharma Companies Made Public Debut on Nasdaq Exchange

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 29, 2021 at 11:12 PM.

  1. #1 cafead, Jul 29, 2021 at 11:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Cambridge, Mass.-based Nuvalent, Inc., which is focused on developing precision therapies for kinase targets in oncology, made its debut on the Nasdaq Exchange this morning, a mere seven months after emerging from stealth mode.

    The company raised approximately $165.75 million from the sale of 9,750,000 shares of common stock at $17 per share. The stock is trading on the Nasdaq under the ticker symbol “NUVL.”

    article source
     
    Quote

Reply to Thread